Keir G - Search Results

1

Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders.

Gnanapavan S, Hegen H, Khalil M, Hemmer B, Franciotta D, Hughes S, Hintzen R, Jeromin A, Havrdova E, Tumani H, Bertolotto A, Comabella M, Frederiksen J, Álvarez-Cermeño JC, Villar L, Galimberti D, Myhr KM, Dujmovic I, Fazekas F, Ionete C, Menge T, Kuhle J, Keir G, Deisenhammer F, Teunissen C, Giovannoni G. Gnanapavan S, et al. Among authors: keir g. Neurology. 2014 Sep 23;83(13):1210-6. doi: 10.1212/WNL.0000000000000809. Epub 2014 Aug 22. Neurology. 2014. PMID: 25150289

2

The clinical significance of an intrathecal monoclonal immunoglobulin band: a follow-up study.

Davies G, Keir G, Thompson EJ, Giovannoni G. Davies G, et al. Among authors: keir g. Neurology. 2003 Apr 8;60(7):1163-6. doi: 10.1212/01.wnl.0000055864.08740.cb. Neurology. 2003. PMID: 12682325 Clinical Trial.

3

Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis.

Giovannoni G, Morris PR, Keir G. Giovannoni G, et al. Among authors: keir g. Ann Neurol. 2000 May;47(5):684-5. Ann Neurol. 2000. PMID: 10805348 No abstract available.

4

Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, Ohman S, Racke MK, Sharief M, Sindic CJ, Sellebjerg F, Tourtellotte WW. Freedman MS, et al. Among authors: keir g. Arch Neurol. 2005 Jun;62(6):865-70. doi: 10.1001/archneur.62.6.865. Arch Neurol. 2005. PMID: 15956157

5

Growth associated protein (GAP-43): cloning and the development of a sensitive ELISA for neurological disorders.

Gnanapavan S, Yousaf N, Heywood W, Grant D, Mills K, Chernajovsky Y, Keir G, Giovannoni G. Gnanapavan S, et al. Among authors: keir g. J Neuroimmunol. 2014 Nov 15;276(1-2):18-23. doi: 10.1016/j.jneuroim.2014.07.008. Epub 2014 Jul 23. J Neuroimmunol. 2014. PMID: 25175067

6

Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis.

Giovannoni G, Green A, Keir G, Thompson EJ. Giovannoni G, et al. Among authors: keir g. Ann Neurol. 1996 Jul;40(1):128-9. doi: 10.1002/ana.410400123. Ann Neurol. 1996. PMID: 8687184 No abstract available.

7

Neural cell adhesion molecule--description of a CSF ELISA method and evidence of reduced levels in selected neurological disorders.

Gnanapavan S, Grant D, Illes-Toth E, Lakdawala N, Keir G, Giovannoni G. Gnanapavan S, et al. Among authors: keir g. J Neuroimmunol. 2010 Aug 25;225(1-2):118-22. doi: 10.1016/j.jneuroim.2010.04.020. Epub 2010 Jun 1. J Neuroimmunol. 2010. PMID: 20605643

8

Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies.

Candler PM, Dale RC, Griffin S, Church AJ, Wait R, Chapman MD, Keir G, Giovannoni G, Rees JH. Candler PM, et al. Among authors: keir g. J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):507-12. doi: 10.1136/jnnp.2005.078105. J Neurol Neurosurg Psychiatry. 2006. PMID: 16543530 Free PMC article.

9

Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis.

Giovannoni G, Lai M, Kidd D, Thorpe JW, Miller DH, Thompson AJ, Keir G, Feldmann M, Thompson EJ. Giovannoni G, et al. Among authors: keir g. Brain. 1997 Jan;120 ( Pt 1):1-13. doi: 10.1093/brain/120.1.1. Brain. 1997. PMID: 9055793

10

Progression in multiple sclerosis is associated with low endogenous NCAM.

Gnanapavan S, Ho P, Heywood W, Jackson S, Grant D, Rantell K, Keir G, Mills K, Steinman L, Giovannoni G. Gnanapavan S, et al. Among authors: keir g. J Neurochem. 2013 Jun;125(5):766-73. doi: 10.1111/jnc.12236. Epub 2013 Apr 19. J Neurochem. 2013. PMID: 23495921 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters